Left ventricular hypertrophy and cardiovascular risk stratification: Impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives

被引：0
|
作者：
Meani, S.
Cuspidi, C.
Valerio, C.
Fusi, V.
Sala, C.
Zanchetti, A.
机构：
[1] Osped Maggiore, IRCCS, Ist Med Cardiovasc, I-20122 Milan, Italy
[2] Univ Studi, Ist Med Cardiovasc, Milan, Italy
[3] Ctr Interuniv Fisiol Clin & Ipertens, Milan, Italy
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 44 条
  • [41] Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
    G McInnes
    T A Burke
    G Carides
    Journal of Human Hypertension, 2006, 20 : 51 - 58
  • [42] Negative Impact of Cardiovascular Risk Factors on Left Atrial and Left Ventricular Function Related to Aortic Stiffness -New Application of 2-Dimensional Speckle-Tracking Echocardiography-
    Oishi, Yoshifumi
    Miyoshi, Hirokazu
    Iuchi, Arata
    Nagase, Norio
    Ara, Nusrat
    Oki, Takashi
    CIRCULATION JOURNAL, 2013, 77 (06) : 1490 - 1498
  • [43] Screening for left ventricular systolic dysfunction in the community by use of hand-held echocardiography, N-terminal Pro-Brain Natrituretic Peptide or both, a cost-effectiveness analysis
    Galasko, GI
    Lahiri, A
    Barnes, SC
    Collinson, P
    Senior, R
    CIRCULATION, 2003, 108 (17) : 715 - 715
  • [44] Cost-effectiveness and budget impact o f liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective
    Shah, Dhvani
    Risebrough, Nancy A.
    Perdrizet, Johnna
    Iyer, Neeraj N.
    Gamble, Cory
    Dang-Tan, Tam
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 791 - 803
12345